552P Safety and efficacy of long-term exposure (LTE) to tislelizumab in Chinese patients with advanced solid tumours

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []